Singapore markets close in 5 hours 8 minutes

Vanda Pharmaceuticals Inc. (0LKB.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
5.32+1.26 (+31.03%)
At close: 07:14PM BST
Full screen
Previous close4.06
Open0.00
Bid0.00 x N/A
Ask0.00 x N/A
Day's range0.00 - 0.00
52-week range
Volume1,020
Avg. volume3,266
Market cap2.751M
Beta (5Y monthly)0.78
PE ratio (TTM)0.16
EPS (TTM)0.32
Earnings date01 May 2024 - 06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share

    On Wednesday, Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) confirmed that, since March 2024, it had received several unsolicited proposals from Future Pak LLC to acquire all of Vanda’s outstanding shares. The most recent proposal offered $7.25 – $7.75 per share, subject to certain terms and conditions. The current proposal implies a premium of 79.0% to 91.4% to Vanda’s closing price of $4.05 as of April 16, 2024. The Vanda Board of Directors concluded that the offers were not in the company’s and it

  • PR Newswire

    Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan

    Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today announced that its Board of Directors (the "Board") has adopted a limited duration stockholder rights plan (the "Rights Plan") to protect stockholder interests and maximize value for all stockholders. The Rights Plan is effective immediately.

  • PR Newswire

    Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak

    Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that, since March 2024, it received several unsolicited proposals from Future Pak, LLC ("Future Pak"), to acquire all of the outstanding shares of Vanda (the "Conditional Proposals"). The most recent proposal from April 1 offered $7.25 - $7.75 per share, subject to certain terms and conditions.